Industries

The healthcare industry is rapidly changing. Regulatory agencies want higher levels of quality and service, as well as lower costs. Healthcare consumers and their insurers are demanding the same. Traditional care delivery and management systems are quickly becoming antiquated, forcing organizations to adapt. Industry suppliers are scrambling to keep pace with new technologies, growing demand and heightened FDA oversight.

The FDA has maintained software validation as a core quality assurance requirement among medical device and pharmaceutical companies for some time now. Yet an ever increasing number of companies fail to execute an adequate validation program as evidenced by the fast-rising number of FDA regulatory enforcement actions. Addressing an FDA 483 or warning letter is disruptive and expensive-especially if it requires the retroactive validation of a process, system, piece of equipment or working environment.

EngiSystems' experienced consultants help medical device and pharmaceutical manufacturers maintain their team's momentum by sourcing experts as-needed to address the demanding challenges of FDA regulatory compliance. With EngiSystems on-site, your team is free to focus on market opportunities without the distraction of staffing and managing a validation group.